Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
In contrast, no statistically significant between‐group differences were detected in postprandial blood glucose fluctuation amplitude, maximum blood glucose fluctuation amplitude, glycated hemoglobin, 0.5‐hour C‐peptide, serum creatinine, total protein, total cholesterol, low‐density lipoprotein cholesterol, hemoglobin, red blood cells, white blood cells, C‐reactive protein, 25‐hydroxyvitamin D, urinary microalbumin, potassium, sodium, calcium, urinary protein, insulin autoantibodies (IAA), tyrosine phosphatase antibodies (IA‐2A), glutamic acid decarboxylase antibodies (GADA), zinc transporter 8 antibodies (ZnT8A), and pancreatic islet cell antibodies (ICA) (all p ≥ 0.05).
Source: 3.4. Analysis of Hematological Test Indicators Between the Prolonged‐Interval Group and the Nonprolonged‐Interval Group. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cross-sectional study.
Cross-sectional study
Examines a population at a particular point in time.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Autoimmune Phenotype Confirmation Intervals and Clinical Indicators in Patients With Latent Autoimmune Diabetes in Adults (LADA) in Southwest China: A Multicenter Retrospective Cross‐Sectional Study
Source: Article title.
Electronic medical records of all enrolled patients were retrospectively extracted to collect timestamped information on initial diabetes diagnosis and subsequent LADA confirmatory testing.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Autoimmune Phenotype Confirmation Intervals and Clinical Indicators in Patients With Latent Autoimmune Diabetes in Adults (LADA) in Southwest China: A Multicenter Retrospective Cross‐Sectional Study
Cross-sectional study · Journal of Diabetes Research · 2026
Original publication title
Autoimmune Phenotype Confirmation Intervals and Clinical Indicators in Patients With Latent Autoimmune Diabetes in Adults (LADA) in Southwest China: A Multicenter Retrospective Cross‐Sectional Study
Copyright © 2026 Qiang Zhang et al. Journal of Diabetes Research published by John Wiley & Sons Ltd.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Patients with latent autoimmune diabetes in adults (LADA) share overlapping clinical phenotypes with Type 2 diabetes mellitus. Extended autoimmune phenotype confirmation intervals and higher complication risks are observed alongside this phenotypic overlap. Real‐world epidemiological data characterizing this interval and relevant clinical indicators remain scarce for Southwest China. This study is aimed at quantifying the duration of this interval and identifying clinical indicators of prolonged confirmation intervals among hospitalized patients in this understudied region.
Source: BackgroundAbstract: What methods does the paper describe?
This multicenter retrospective cross‐sectional study recruited consecutive inpatients with confirmed LADA from tertiary hospitals across Southwest China between January 2019 and June 2025. Standardized extraction of baseline demographic, clinical, and laboratory data was performed from electronic medical records. The primary binary outcome was defined as the confirmation interval from initial diabetes diagnosis to autoimmune serological testing, which was dichotomized to distinguish patients with prolonged confirmation intervals. Multivariable binary logistic regression was used to identify clinical indicators showing synchronous coexistence with the intervals.
The area under the curve (AUC) and Hosmer: Lemeshow goodness‐of‐fit test were adopted to evaluate the discrimination and calibration of the regression model.
Source: MethodsAbstract: Results
A total of 578 eligible participants were included, among whom 363 (62.8%) presented prolonged confirmation intervals. The median interval was 2 (0, 7) years across the overall cohort and 5 (2, 10) years for the prolonged‐interval group. The multivariate regression model showed satisfactory goodness‐of‐fit. Seven clinical indicators of prolonged confirmation intervals were divided into three categories: demographic and behavioral characteristics including educational level and duration of alcohol consumption; metabolic biomarkers measured at LADA confirmation including inpatient mean blood glucose and 2‐hour C‐peptide levels; advanced diabetic manifestations including diabetic retinopathy, diabetic ketosis, and polypharmacy.
Source: ResultsAbstract: Conclusions
A substantial proportion of hospitalized LADA patients in Southwest China present prolonged autoimmune confirmation intervals. Seven clinical indicators showing stable synchronous coexistence with the intervals were identified. The findings provide region‐specific real‐world evidence characterizing clinical features of patients with such intervals to guide inpatient clinical management. Multicenter prospective studies enrolling community populations are required to examine whether these synchronously coexisting indicators apply to broader patient groups.
Source: ConclusionsAuthors’ abstract
Background
Patients with latent autoimmune diabetes in adults (LADA) share overlapping clinical phenotypes with Type 2 diabetes mellitus. Extended autoimmune phenotype confirmation intervals and higher complication risks are observed alongside this phenotypic overlap. Real‐world epidemiological data characterizing this interval and relevant clinical indicators remain scarce for Southwest China. This study is aimed at quantifying the duration of this interval and identifying clinical indicators of prolonged confirmation intervals among hospitalized patients in this understudied region.
Methods
This multicenter retrospective cross‐sectional study recruited consecutive inpatients with confirmed LADA from tertiary hospitals across Southwest China between January 2019 and June 2025. Standardized extraction of baseline demographic, clinical, and laboratory data was performed from electronic medical records. The primary binary outcome was defined as the confirmation interval from initial diabetes diagnosis to autoimmune serological testing, which was dichotomized to distinguish patients with prolonged confirmation intervals. Multivariable binary logistic regression was used to identify clinical indicators showing synchronous coexistence with the intervals.
The area under the curve (AUC) and Hosmer: Lemeshow goodness‐of‐fit test were adopted to evaluate the discrimination and calibration of the regression model.
Results
A total of 578 eligible participants were included, among whom 363 (62.8%) presented prolonged confirmation intervals. The median interval was 2 (0, 7) years across the overall cohort and 5 (2, 10) years for the prolonged‐interval group. The multivariate regression model showed satisfactory goodness‐of‐fit. Seven clinical indicators of prolonged confirmation intervals were divided into three categories: demographic and behavioral characteristics including educational level and duration of alcohol consumption; metabolic biomarkers measured at LADA confirmation including inpatient mean blood glucose and 2‐hour C‐peptide levels; advanced diabetic manifestations including diabetic retinopathy, diabetic ketosis, and polypharmacy.
Conclusions
A substantial proportion of hospitalized LADA patients in Southwest China present prolonged autoimmune confirmation intervals. Seven clinical indicators showing stable synchronous coexistence with the intervals were identified. The findings provide region‐specific real‐world evidence characterizing clinical features of patients with such intervals to guide inpatient clinical management. Multicenter prospective studies enrolling community populations are required to examine whether these synchronously coexisting indicators apply to broader patient groups.
Publication and source details
Original title: Autoimmune Phenotype Confirmation Intervals and Clinical Indicators in Patients With Latent Autoimmune Diabetes in Adults (LADA) in Southwest China: A Multicenter Retrospective Cross‐Sectional Study
Qiang Zhang; Haojie Zhou; Guniqing Zhu; Ran Li; Weiwei Xu; Ruonan Lin; Yuan Zhao; Hui Li; Xiangfu Gu; Xiaoli Zhu
Journal of Diabetes Research · 2026
Copyright © 2026 Qiang Zhang et al. Journal of Diabetes Research published by John Wiley & Sons Ltd.2026https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the https://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. Kuanren Talents Program of the Second Affiliated Hospital of Chongqing Medical University Yunnan Provincial Department of Education Science Research Fund Project10.13039/501100019413 2025Y11862026Y1327Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T00:44:55.129518+00:00
DOI: 10.1155/jdr/7481709 · PMC13552359